Article snapshot taken from[REDACTED] with creative commons attribution-sharealike license.
Give it a read and then ask your questions in the chat.
We can research this topic together.
Scottish medical researcher
David A. Flockhart (1952–2015) was a Scottish medical researcher who was a leader in the field of personalised medicine. He was especially known for his work on factors affecting the use of tamoxifen to treat breast cancer such as variability in the level of the CYP2D6 enzyme.
References
"In death, there is life", The Economist, p. 84, 26 March 2016